MUC1 and interstitial lung disease: In the present study, we confirmed the role of KL‐6, detected with AIA‐360 (FEIA system, Tosoh Biosciences) and CL‐AIA (CLEIA system, Tosoh Biosciences) instruments, as a diagnostic and prognostic marker for fibrotic ILD patients.